RSSDI Repository, Complications of Diabetes Demonstration
RSSDI Repository, Complications of Diabetes Demonstration

Have a Question?

If you have any question you can ask below or enter what you are looking for!

Advanced Search
  • Home/
  • Article /
  • Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?

Tacrolimus and mycophenolate mofetil as second-line treatment in autoimmune hepatitis: Is the evidence of sufficient quality to develop recommendations?

Add to Collection
Clinical Guidelines and Recommendations M Abdollahi, NK Ekrami, M Ghojazadeh… - World Journal of …, 2020 - ncbi.nlm.nih.gov

Chapter : Section2
Journal Year : 2020
Cited by : 4

… Biochemical remission was the primary outcome for our study… , to reach the most likely definition of remission for that study. … side-effects, while diabetes mellitus, nephrotoxicity, pruritus …..... Read More

Keywords : ['sufficient quality', 'secondline treatment', 'mycophenolate mofetil', 'develop recommendation', 'autoimmune hepatitis', 'tacrolimus', 'evidence']
PubMed Link : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7579758/
Google Scholar Link : https://scholar.google.com/scholar?cites=15088394754011383455&as_sdt=5,34&sciodt=0,34&hl=en&num=20